1. 1) The Health and Welfare Statistics Association Investigators Group. (2006) Mortality by cause, sex, and age specific ranges. J. Health Welfare Statistics. suppl. 52: 378-381. (in Japanese)
2. 2) Watanabe, H., Saitoh, M., Mishina, T., Igari, D., Tanahashi, Y., Harada, K. and Hisamichi, S. (1977) Mass screening program for prostatic diseases with transrectal ultrasonotomography. J. Urol. 117: 746-748.
3. 3) Meyer, F., Moore, L., Bairati, I. and Fradet, Y. (1999) Downward trend in prostate cancer mortality in Ouebec and Canada. J. Urol. 161: 1189-1191.
4. 4) Bartsch, G., Horninger, W., Klocker, H., Reissigl, A., Oberaigner, W., Schonitzer, D., Severi, G., Robertson, C. and Boyle, P. (2001) Prostate cancer mortality after introduction of prostate-specific antigen mass screening in the Federal State of Tyrol, Austria. Urology 58: 417-424.
5. 5) Saito, T., Komatsubara, S., Nishiyama, T., Tomita, Y., Katagiri, A. and Wakabayashi, M. (2005) Prostate cancer screening in Niigata Prefecture. Jap. J. Urol. Surg. 18: 994-996. (in Japanese)